share_log

Teladoc Health | 4: Statement of changes in beneficial ownership of securities-Officer Trencher Daniel

SEC announcement ·  Apr 17 17:00
Summary by Moomoo AI
Daniel Trencher, the Chief Strategy Officer of Teladoc Health, Inc. (TDOC), executed a sale of 1,000 shares of common stock on April 17, 2024. The transaction was carried out as an open market or private sale at a price of $13.21 per share, resulting in a total value of $13,210. Following the sale, Trencher's direct holdings in the company amount to 26,192 shares. The transaction is currently reported as in progress.
Daniel Trencher, the Chief Strategy Officer of Teladoc Health, Inc. (TDOC), executed a sale of 1,000 shares of common stock on April 17, 2024. The transaction was carried out as an open market or private sale at a price of $13.21 per share, resulting in a total value of $13,210. Following the sale, Trencher's direct holdings in the company amount to 26,192 shares. The transaction is currently reported as in progress.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more